跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUNITINIB EGIS 12,5 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SUNITINIB EGIS 12,5 MG CAPSULAS DURAS EFG
Approved
STANDARD
SUNITINIB EGIS 12,5 MG CAPSULAS DURAS EFG
Egis Pharmaceuticals Plc.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 17, 2021
Approval ID
e3cb6978839e4df3
Company
Egis Pharmaceuticals Plc.
Type
Standard
Approval Details
Approval Id
e3cb6978839e4df3
Drug Cima Aemps Name
SUNITINIB EGIS 12,5 MG CAPSULAS DURAS EFG
Register Number
86031
Holder Company Name
Egis Pharmaceuticals Plc.
Marketing Company Name
Egis Pharmaceuticals Plc.
Authorization Date
2021-06-17
Dosage Form
CÁPSULA DURA
Dose
12,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Egis Pharmaceuticals Plc.
Active Ingredients
SUNITINIB CICLAMATO
18,12 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 17, 2021
Approval ID
e3cb6978839e4df3
Type
Standard
Back to CIMA-AEMPS Approvals